Oxford Covid-19 vaccine produces immune response across all ages - AstraZeneca

Oxford Covid-19 vaccine produces immune response across all ages - AstraZeneca

Responding to a question over the BJP's election manifesto promising free coronavirus vaccine for everyone in Bihar, Â Dr V K Paul, NITI Aayog member (Health), who also heads the National Task Force on Covid-19, at a press briefing said that resources will not be an issue in ensuring access to vaccines as and when it becomes available.

The vaccine, being developed with the University of Oxford, is one of the world's leading Covid-19 vaccine candidates.

The UK drugmaker also said that adverse reactions were lower among the elderly.

Developed by the University of Oxford in conjunction with English-Swedish multinational pharmaceutical company AstraZeneca Plc, the Astra-Oxford vaccine is one of many first runners in the race to protect against the virus.

An AstraZeneca spokesperson told Business Insider: "It is encouraging to see immunogenicity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the Covid-19 disease severity is higher".

The vaccine triggered protective antibodies and T-cells in older age groups which will substantially decrease the mortality rate due to the contagious virus.

This could potentially be seen as a game-changer in the battle against the novel coronavirus, which has infected more than 43 million people worldwide, killed at least 1.15 million people, shuttered swathes of the global economy, and turned normal life upside down for billions of people.


The Ministry of Food and Drug Safety said in a statement that it had formed a screening team to review the vaccine candidate, with an application for formal approval expected in 90 days under its rapid approval programme for COVID-19 treatments and vaccines.

British Health Secretary Matt Hancock said a vaccine was not yet ready, but he was preparing logistics for a possible roll out.

The findings came from blood tests carried out on a subset of older participants in the vaccine trials.

Details of the latest findings are expected to be published shortly in a clinical journal, the Financial Times reported.

"Our ongoing trials will provide further data, but this marks a key milestone and reassures us that the vaccine is safe for use and induces strong immune responses in both parts of the immune system in all adult groups".

The findings come after the Food and Drug Administration allowed AstraZeneca on Friday to resume its vaccine trials in the USA after a participant reported a "severe adverse reaction" on September 6.

Related:

Comments

Latest news

Philippines almost 1,800 people evacuate as Tropical Storm Moulaf approaches
PAGASA said Quinta will continue intensifying in the West Philippine Sea after crossing the Philippine archipelago. Authorities were clearing roads of fallen trees and debris in some towns after the typhoon passed, he said.

Nasa 'definitively' confirms water on the sunlit surface of the Moon
It was able to precisely observe wavelengths of water molecules with an infrared spectrometer, Honniball explained in the call. A new study finds there are 40,000 square kilometres of shadows, mostly near the moon's poles, that could hide ice deposits.

Hurricane Zeta makes landfall on Yucatan Peninsula
Zeta, the 27th named storm of the season, is expected strengthen over the next 24 hours leading up to landfall in the U.S. Zeta should turn toward the north tonight, and a faster northward to north-northeastward motion is expected on Wednesday.

Samsung chairman dies at 78, East Asia News & Top Stories
By introducing the Galaxy Note in 2011, Samsung created a new product niche known as the phablet, a smartphone-tablet hybrid. On October 25, Samsung Group announced that Samsung's long-time chairman, Lee Kun-hee, died at 78, with family by his side.

Announces 217 more cases of COVID-19 but no new deaths
South Dakota led the nation with the highest positive test rate at 40%, followed by Idaho at 34% and Wyoming at 29%. 5,101 people are under active health monitoring for being exposed to a known case of the virus.

Other news